INTernational REsearch Programme on Psychoses In Diverse settings
INTREPID II is a programme of research on schizophrenia and other psychoses that is being conducted in Chennai (India), Ibadan (Nigeria) and Trinidad.
It builds on INTREPID I, a Wellcome Trust-funded pilot study, in which we developed robust and comparable methods with which to identify and follow up individuals with psychotic disorders across diverse settings.
INTREPID II is a collaboration between the Schizophrenia Research Foundation (SCARF; Chennai), the University of Ibadan (Nigeria), the University of the West Indies at St Augustine (Trinidad), the London School of Hygiene and Tropical Medicine (UK), and the Institute of Psychiatry, Psychology & Neuroscience, King's College London (UK). The programme is funded by the Medical Research Council (MRC) of the United Kingdom
Together, the two phases of the INTREPID programme are designed to:
a) Develop comparable methods for the study of schizophrenia and other psychotic disorders in diverse settings and establish an extensive network of providers and key informants to help provide comprehensive estimates of incidence (Phase 1: completed, read about it here); and
b) Implement these methods in a three-country study of the epidemiology, phenomenology, aetiology and outcomes of schizophrenia and other psychotic disorders (Phase 2: in progress)
This website has a public area in which you will find information about all aspects of the programme, and a members’ area which we use as a platform for sharing information within the research team.
We are always keen to develop collaborations and would be pleased to hear from colleagues conducting research on schizophrenia and psychotic disorders around the world.